All In Biotech

Free tool

FAERS Monitor: Spravato

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 211243 or its brand name (Spravato, Esketamine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

18,798

Serious

13,122

70% of reports

Hospitalization

3,187

Death reported

736

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dissociation3,903
  • sedation2,816
  • suicidal ideation1,446
  • drug ineffective1,134
  • nausea1,006
  • depression956
  • hypertension917
  • product dose omission issue852
  • hospitalisation850
  • anxiety775
  • vomiting764
  • dizziness670
  • blood pressure increased584
  • feeling abnormal521
  • off label use448

Reports by year received

View as table
YearReports
20151
20173
20181
2019677
20201,004
20211,249
20221,463
20232,111
20243,262
20256,094
20262,933

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,035,361 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
dissociationSignal3,9031158.51110.42,218,028
sedationSignal2,816134.7129.9333,771
suicidal ideationSignal1,44617.917.122,850
hospitalisationSignal8506.25.83,724
hypertensionSignal9174.94.62,825
depressionSignal9564.74.42,815
blood pressure increasedSignal5844.34.01,473
product dose omission issueSignal8523.23.01,338
anxietySignal7753.12.81,079
feeling abnormalSignal5212.42.2444
vomiting7641.81.7287
dizziness6701.51.4115
nausea1,0061.41.3131
drug ineffective1,1341.00.92
off label use4480.60.5149

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.